Expert Opinion on Drug Safety

Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
pp. 675-685(11)
Author: Robson, Philip

Safety and efficacy of rivaroxaban for thromboprophylaxis following lower limb surgery: an update
pp. 687-696(10)
Authors: Goff, Thomas; Kontakis, George; Giannoudis, Peter V

Update on the safety of testosterone therapy in cardiac disease
pp. 697-704(8)
Authors: Aaronson, Alistair J; Morrissey, Ryan P; Nguyen, Cam T; Willix, Robert; Schwarz, Ernst R

Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy
pp. 705-714(10)
Authors: Abarientos, Crispin; Sperber, Kirk; Shapiro, Deborah L; Aronow, Wilbert S; Chao, Chun Peng; Ash, Julia Y

The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis
pp. 715-726(12)
Authors: Brinkman, Ithamar Heber; Laar, Mart AFJ van de; Jansen, Tim L; van Roon, Eric N

Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment
pp. 727-749(23)
Author: Kahan, Barry

Drugs with anticholinergic properties: a current perspective on use and safety
pp. 751-765(15)
Authors: Gerretsen, Philip; Pollock, Bruce G

Safe use of long-acting β-agonists: what have we learnt?
pp. 767-778(12)
Author: Sears, Malcolm R

Safety and efficacy of bilastine: a new H₁-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria
pp. 779-793(15)
Author: Church, Martin K

Drug safety evaluation of amlodipine
pp. 795-804(10)
Authors: Derosa, Giuseppe; Maffioli, Pamela

Review of fesoterodine
pp. 805-808(4)
Authors: Vella, Maria; Cardozo, Linda

Drug safety evaluation of adefovir in HBV infection
pp. 809-818(10)
Authors: Viganò, Mauro; Lampertico, Pietro; Colombo, Massimo

Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer
pp. 819-826(8)
Authors: Scott, Sarah M; Brown, Myles; Come, Steven E

Promises and partnership: FDA's Critical Path Initiative and its intersection with pharmacology: an ASPET 2011 annual meeting symposium
pp. 827-837(11)
Author: Cavero, Icilio